Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- (-) Advertising (25)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
393 result(s) found, displaying 226 to 250
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period - melatonin
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the current Poisons Standard in relation to melatonin.
-
Scheduling submissionsPublic submissions on scheduling matters referred to the Joint ACMS-ACCS #25 meetings held in June 2020 - Nicotine
-
Scheduling submissionsPublic submissions made in response to the proposed amendments to the Poisons Standard referred to the ACMS #31 and Joint ACMS-ACCS #25 meetings held in June 2020
-
Corporate reportsOverview of therapeutic goods advertising complaints handling and compliance for 2019-20
-
Scheduling submissionsPublic submissions on matters referred to the March 2020 scheduling meetings, and received during the interim consultation period
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 13 October 2020
-
Meeting statementsA meeting of the TGACC was held on 27 August 2020. A communique has been published.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Scheduling decisions (final)Public notice of the Delegates' final decisions to amend (or not amend) the Poisons Standard.
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 16 July 2020
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Scheduling decisions (interim)Invitation for further comment. Closing date: 28 August 2020
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Meeting statementsAdvisory Committee on Medical Devices
-
Corporate reportsFinal Report on the impact of advertising reforms from the Expert Panel Review of Medicines and Medical Devices Regulation, and other initiatives
-
Corporate reportsThe independent review is complete and the report now published.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement